Nicotinamide pretreatment protects cardiomyocytes against hypoxia-induced cell death by improving mitochondrial stress

Pharmacology

Volumn 90, Issue 1-2, 2012, Pages 11-18

  Tong, Da Li ^a   Zhang, Dong Xia ^a   Xiang, Fei ^a   Teng, Miao ^a   Jiang, Xu Pin ^a   Hou, Jing Ming ^a   Zhang, Qiong ^a   Huang, Yue Sheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cardioprotection; Mitochondrial stress; Nicotinamide

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; CATALASE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REACTIVE OXYGEN METABOLITE; RECEPTOR INTERACTING PROTEIN 140; SUPEROXIDE DISMUTASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL DEATH; CELL HYPOXIA; CELL LEVEL; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART MUSCLE CELL; HEART PROTECTION; ISCHEMIC HEART DISEASE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL STRESS; NONHUMAN; OXIDATIVE STRESS; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL HYPOXIA; CELLS, CULTURED; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MYOCYTES, CARDIAC; NECROSIS; NIACINAMIDE; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; VITAMIN B COMPLEX;

EID: 84862223755     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000338628     Document Type: Article

References (32)

1. Shah DJ, Kim HW, Kim RJ: Evaluation of ischemic heart disease. Heart Fail Clin 2009; 5:315-332, v.
2. Karamitsos TD, Dall'Armellina E, Choud-hury RP, Neubauer S: Ischemic heart disease: comprehensive evaluation by cardiovascular magnetic resonance. Am Heart J 2011; 162: 16-30.
3. Cadenas S, Aragones J, Landazuri MO: Mi-tochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease. Cardiovasc Res 2010; 88:219-228.
4. Tompkins AJ, Burwell LS, Digerness SB, Zaragoza C, Holman WL, Brookes PS: Mito-chondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition. Biochim Biophys Acta 2006; 1762: 223-231.
5. Di Lisa F, Bernardi P: Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 2006; 70: 191-199.
6. Khan S, Salloum F, Das A, Xi L, Vetrovec GW, Kukreja RC: Rapamycin confers pre-conditioning-like protection against isch-emia-reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol 2006; 41:256-264.
7. Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A: Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and tro-ponin T plasma levels in patients with stable ischemic cardiomyopathy. Am Heart J 2007; 154:602 e601-e605.
8. Hoane MR, Tan AA, Pierce JL, Anderson GD, Smith DC: Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat. J Neurotrauma 2006; 23: 1535-1548.
9. Mokudai T, Ayoub IA, Sakakibara Y, Lee EJ, Ogilvy CS, Maynard KI: Delayed treatment with nicotinamide (vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats. Stroke 2000; 31:1679-1685.
10. Hoane MR, Gilbert DR, Holland MA, Pierce JL: Nicotinamide reduces acute cortical neu-ronal death and edema in the traumatically injured brain. Neurosci Lett 2006; 408: 35-39.
11. Sukhodub A, Du Q, Jovanovic S, Jovanovic A: Nicotinamide-rich diet protects the heart against ischaemia-reperfusion in mice: a crucial role for cardiac SUR2A. Pharmacol Res 2010; 61: 564-570.
12. Simpson P, Savion S: Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chro-notropic response to isoproterenol. Circ Res 1982; 50: 101-116.
13. Das A, Xi L, Kukreja RC: Phosphodiester-ase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apop-tosis. Essential role of nitric oxide signaling. J Biol Chem 2005; 280: 12944-12955.
14. Rusanen H, Majamaa K, Hassinen IE: Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243AG mutation in mitochondrial DNA. Biochim Bio-phys Acta 2000; 1500:10-16.
15. Loos B, Genade S, Ellis B, Lochner A, Engel-brecht AM: At the core of survival: autopha-gy delays the onset of both apoptotic and ne-crotic cell death in a model of ischemic cell injury. Exp Cell Res 2011; 317: 1437-1453.
16. Xiang F, Huang YS, Zhang DX, Chu ZG, Zhang JP, Zhang Q: Adenosine A1 receptor activation reduces opening of mitochondrial permeability transition pores in hypoxic car-diomyocytes. Clin Exp Pharmacol Physiol 2010; 37: 343-349.
17. Xiang F, Huang YS, Shi XH, Zhang Q: Mito-chondrial chaperone tumour necrosis factor receptor-associated protein 1 protects car-diomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening. FEBS J 2010; 277: 1929-1938.
18. Kim YH, Hwang JH, Noh JR, Gang GT, Tadi S, Yim YH, Jeoung NH, Kwak TH, Lee SH, Kweon GR, Kim JM, Shong M, Lee IK, Lee CH: Prevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidore-ductase 1, associated with NADPH oxidase. Free Radic Biol Med 2012; 52: 880-888.
19. Trichonas G, Murakami Y, Thanos A, Mori-zane Y, Kayama M, Debouck CM, Hisatomi T, Miller JW, Vavvas DG: Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci USA 2010; 107:21695-21700.
20. Galluzzi L, Kepp O, Kroemer G: Rip kinases initiate programmed necrosis. J Mol Cell Biol 2009; 1:8-10.
21. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P: Rip1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 2007; 14:400-410.
22. Lawen A: Apoptosis-an introduction. Bioessays 2003; 25:888-896.
23. Liu CM, Ma JQ, Sun YZ: Puerarin protects rat kidney from lead-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol 2012; 258:330-342.
24. Geiger J, Zou AP, Campbell WB, Li PL: Inhibition of CADP-ribose formation produces vasodilation in bovine coronary arteries. Hypertension 2000; 35: 397-402.
25. Gul R, Kim SY, Park KH, Kim BJ, Kim SJ, Im MJ, Kim UH: A novel signaling pathway of ADP-ribosyl cyclase activation by angioten-sin II in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol 2008; 295:H77-H88.
26. Dong J, Ramachandiran S, Tikoo K, Jia Z, Lau SS, Monks TJ: EGFR-independent activation of p38 MAPK and EGFR-dependent activation of ERK1/2 are required for ros-in-duced renal cell death. Am J Physiol Renal Physiol 2004; 287:F1049-F1058.
27. Woo DK, Shadel GS: Mitochondrial stress signals revise an old aging theory. Cell 2011; 144:11-12.
28. Durieux J, Wolff S, Dillin A: The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 2011; 144: 79-91.
29. Yao H, Sadanaga-Akiyoshi F, Ibayashi S, Iida M: Nicotinamide attenuates focal ischemic brain injury: meta-analysis or mechanism of protection. Stroke 2004; 35: 2757-2758.
30. + levels in ischemic core and penumbra. Neurochem Res 2003; 28:1227-1234.
31. Wang J, Zhai Q, Chen Y, Lin E, Gu W, Mc-Burney MW, He Z: A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol 2005; 170: 349-355.
32. Petrosillo G, Di Venosa N, Moro N, Colan-tuono G, Paradies V, Tiravanti E, Federici A, Ruggiero FM, Paradies G: In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release. Free Rad-ic Biol Med 2011; 50: 477-483.